Skip to main navigation Skip to search Skip to main content

A Phase I/II trial to evaluate the safety, pharmacodynamics and efficacy of MPDL3280A in combination with entinostat bevacizumab in patients with advanced renal cell carcinoma

University at Buffalo

Project: Research

Project Details

StatusActive
Effective start/end date08/15/24 → 08/14/26

Funding

  • Trustees of Indiana University: $105,355.00